HealthEquity, Inc. (HQY) vs Oscar Health, Inc. (OSCR)

A side-by-side comparison of HealthEquity, Inc. and Oscar Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — HQY vs OSCR

growth of $100 · dividends reinvested · last 6y
HQY +9.8% (+1.6%/yr)OSCR -6.8% (-1.2%/yr)HQY compounded faster over this window
050100Start $10020222023202420252026$110$93
HQY OSCR

HQY vs OSCR: by the numbers

  • •OSCR is the larger company ($8.37B vs $7.61B market cap).
  • •OSCR trades at the lower trailing earnings multiple (23.06 vs 32.86 P/E), one valuation lens rather than an overall verdict.
  • •HQY converts more revenue to profit (17.36% vs 3.60% net margin).
  • •OSCR grew revenue faster over the past five years (64.83% vs 12.96% CAGR).

Metrics side by side

Valuation

MetricHQYOSCR
P/E ratio32.8623.06
Forward P/E19.2716.92
PEG ratio0.40N/A
P/S ratio5.590.55
P/B ratio3.824.08
EV / EBITDA17.317.25
FCF yield6.20%51.78%

Profitability

MetricHQYOSCR
Gross margin75.21%14.38%
Operating margin25.61%4.07%
Net margin17.36%3.60%
ROE11.88%26.84%
ROIC8.55%22.98%

Growth (annualized)

MetricHQYOSCR
Revenue CAGR (5Y)12.96%64.83%
EPS CAGR (5Y)83.56%N/A
FCF CAGR (5Y)36.72%80.81%
Total return CAGR (5Y)7.00%14.97%

Frequently asked

Which has the lower trailing P/E, HQY or OSCR?
OSCR has the lower trailing P/E: HQY trades at 32.86 and OSCR at 23.06. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, HQY or OSCR?
Over the past five years, OSCR grew revenue faster — HQY at a 12.96% CAGR versus OSCR at 64.83%.
Is HQY or OSCR more profitable?
HQY runs the higher net margin — HQY at 17.36% versus OSCR at 3.60%.
How have HQY and OSCR total returns compared?
Over the past 5 years, HQY delivered 7.00% and OSCR delivered 14.97% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.